| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis[J]. J Glob Health, 2015, 5: 020415.
|
| 3 |
Zhou MG, Wang HD, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2016, 387 (10015): 251-272.
|
| 4 |
José LLC, Juan JSC, Marc M. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2019 report: future challenges[J]. Arch Bronconeumol, 2020, 56(2): 65-67.
|
| 5 |
Laurin C, Moullec G, Bacon SL, et al. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk[J]. Am J Respir Crit Care Med, 2012, 185(9): 918-923.
|
| 6 |
Pooler A, Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9: 315-330.
|
| 7 |
Arroll B, Goodyear SF, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population[J]. Ann Fam Med, 2010, 8: 348-353.
|
| 8 |
Bratås O, Grønning K, Forbord T. Psychometric properties of the hospital anxiety and depression scale and the general health questionnaire-20 in COPD inpatients[J]. Scand J Caring Sci, 2014, 28(2): 413-420.
|
| 9 |
Evan A, Paul F, Belinda C, et al. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis[J]. Chest, 2013, 144 (3): 766-777.
|
| 10 |
Gratziou Ch, Florou A, Ischaki E, et al. Smoking cessation effectiveness in smokers with COPD and asthma under real life conditions[J]. Respir Med, 2014, 108(4): 577-583.
|
| 11 |
Mirza S, Benzo R. Chronic obstructive pulmonary disease phenotypes：implications for care[J]. Mayo Clin Proc, 2017, 92(7): 1104-1112.
|
| 12 |
Hegerl U, Mergl R. Depression and suicidality in COPD: understandable reaction or independent disorders？[J]. Eur Respir J, 2014, 44 (3): 734-743.
|
| 13 |
Yohannes AM, Willgoss TG, Baldwin RC, et al. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles[J]. Int J Geriatr Psychiatry, 2010, 25 (12): 1209-1221.
|
| 14 |
Omachi TA, Katz PP, Yelin EH, et al. Depression and health-related quality of life in chronic obstructive pulmonary disease[J]. Am J Med, 2009, 122(8): 778.e9-15.
|
| 15 |
Rybka J, Korte SM, Czajkowska MM, et al. The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-γ[J]. Clin Exp Med, 2016, 16(4): 493-502.
|
| 16 |
Hanania NA, Müllerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort[J]. Am J Respir Crit Care Med, 2011, 183: 604-611.
|
| 17 |
Quint JK, Baghai RR, Donaldson GC, et al. Relationship between depression and exacerbations in COPD[J]. Eur Respir J, 2008, 32 (4): 53-60.
|
| 18 |
Yohannes AM, Chen W, Moga AM, et al. Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: A systematic review and meta-analysis of observational studies[J]. J Am Med Dir Assoc, 2017, 18(5): 451.e1-451.e11.
|
| 19 |
Riblet NB, Gottlieb DJ, Hoyt JE, et al. An analysis of the relationship between chronic obstructive pulmonary disease, smoking and depression in an integrated healthcare system[J]. Gen Hosp Psychiatry, 2020, 64: 72-79.
|
| 20 |
Young SN. Elevated incidence of suicide in people living at altitude, smokers and patients with chronic obstructive pulmonary disease and asthma: possible role of hypoxia causing decreased serotonin synthesis[J]. J Psychiatry Neurosci, 2013, 38(6): 423-426.
|
| 21 |
Brent MK, Douglas GK, Perry FR. Creatine for the treatment of depression[J]. Biomolecules, 2019, 9(9): 406.
|
| 22 |
Riblet NB, Gottlieb DJ, Watts BV, et al. Hypoxia-related risk factors for death by suicide in a national clinical sample[J]. Psychiatry Res, 2019, 273: 247-251.
|
| 23 |
Postma DS, Bush A, van den BM. Risk factors and early origins of chronic obstructive pulmonary disease[J]. Lancet, 2015, 385(9971): 899-909.
|
| 24 |
Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking[J]. Chest, 2007, 131(5): 1557-1566.
|
| 25 |
Nunes Sandra OV, Vargas HO, Brum J, et al. A comparison of inflammatory markers in depressed and nondepressed smokers[J]. Nicotine Tob Res, 2012, 14(5): 540-546.
|
| 26 |
Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from？[J]. BMC Med, 2013, 11: 200.
|
| 27 |
Fluharty M, Taylor AE, Grabski M, et al. The association of cigarette smoking with depression and anxiety: A systematic review[J]. Nicotine Tob Res, 2017, 19(1): 3-13.
|
| 28 |
Prochaska JJ, Das S, Young-Wolff KC. Smoking, mental illness, and public health[J]. Annu Rev Public Health, 2017, 38: 165-185.
|
| 29 |
Agustí A, Celli B, Faner R. What does endotyping mean for treatment in chronic obstructive pulmonary disease？[J]. Lancet, 2017, 390(10098): 980-987.
|
| 30 |
Sidhaye VK, Nishida K, Martinez FJ. Precision medicine in COPD: where are we and where do we need to go？[J]. Eur Respir Rev, 2018, 27(149): 180022.
|
| 31 |
Cinciripini PM, Green CE, Robinson JD, et al. Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment[J]. Psychopharmacology (Berl), 2017, 234(11): 1769-1779.
|
| 32 |
Taylor G, McNeill A, Girling A, et al. Change in mental health after smoking cessation: systematic review and meta-analysis[J]. BMJ, 2014, 348: g1151.
|